Korea Institute of Radiological & Medical Sciences
发明人:
Ji Yeon Ann,Jie Young Song,Hyun-Kyoung Choi,Hwa Ni Ryu,Sang Gu Hwang,Ky-Youb Nam,In-Sung Jung
申请号：
GB202001368
公开号：
GB2579149A
申请日:
2018.02.28
申请国别(地区):
GB
年份:
2020
代理人:
摘要：
The present invention relates to a receptor tyrosine kinase activity inhibiting compound represented by Chemical Formula 1 and Chemical Formula 2, wherein the compound represented by Chemical Formula 1 and Chemical Formula 2 has been confirmed to inhibit the growth of cancer cells through inhibiting kinase activity and has been confirmed to enhance cancer cell apoptosis when used in combination with existing anticancer drugs or radiation therapy. Accordingly, the compound represented by Chemical Formula 1 and Chemical Formula 2 can be provided as a pharmaceutical composition for preventing or treating cancer, or as a composition for increasing the anti-cancer treatment effect of anti-cancer treatments and radiation therapy.
